Navigation Links
BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
Date:9/18/2007

ROCKVILLE, Md., Sept. 18 /PRNewswire/ -- BioReliance Corporation, a leading contract services organization for the biopharmaceutical and pharmaceutical industries, announced today the launch of iNet, a proprietary information technology system that enables customers to submit test article details via controlled and secure Internet access from any location worldwide. In real-time, BioReliance clients can now view the status of current and past studies, keep informed of expected completion dates, download reports, and allow colleagues to view testing status-all in one online environment.

BioReliance developed iNet to simplify test article submissions and to promote instantaneous communications between clients and internal project managers. "As a result of these efforts," stated Tim Derrington, President and CEO of BioReliance, "our customers are now armed with a web-enabled application that offers a precise picture of their project's current and future status. We look forward to greatly expanding our iNet user base in the upcoming months and continuing to develop and integrate new technologies that will enhance our customers' service experiences with BioReliance."

Pavel Khrimian, Senior Project Manager, commented, "The response from our early-access iNet users has been very positive. Customers are using the projected lab initiation and report completion dates to facilitate their project planning efforts. In addition, the electronic template used for sample submission has simplified their paperwork, while making the entire process more timely and manageable."

Judith Apshago, Senior Director of Global IT, also added, "A lot of effort was placed into making iNet user-friendly, secure and compliant. As a result, preliminary users have navigated through the submission process with little difficulty. In addition, we have implemented multiple layers of security both on the front end and the back end to create an extremely secure online environment that validates users and ensures data integrity."

iNet is compliant with 21 CFR Part 11 for user authentication, and data exchange over the web is protected by use of Secured Sockets Layer certificates procured from VeriSign(R). It is also compatible with both Windows and Mac operating systems.

The iNet application is available to US biologics testing customers upon request. This service will be available at a future date for studies conducted in the UK, as well as for viral clearance and toxicology clients.

About BioReliance

BioReliance Corporation is a leading contract services organization, offering more than 1,000 tests or services related to biologics safety testing, in vitro and in vivo toxicology, viral manufacturing and lab animal health diagnostics for the biopharmaceutical and pharmaceutical industries. The Company provides cost-effective services to over 600 clients annually, including most of the largest pharmaceutical and biopharmaceutical companies in the world. BioReliance is headquartered in Rockville, Maryland and has additional facilities in Glasgow, Scotland and Stirling, Scotland. For more information, visit http://www.bioreliance.com.

Contact

Cindy Goldstein

Director, Global Marketing

BioReliance Corporation

cindy.goldstein@bioreliance.com

+1 301.610.2544


'/>"/>
SOURCE BioReliance Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Merge launches diagnostic mammography workstation in Europe
11. Einstein Wireless launches cellular alert system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... , ... October 10, 2017 , ... Dr. Bob Harman, ... his local San Diego Rotary Club. The event entitled “Stem Cells ... and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Biology News(10 mins):